Literature DB >> 21527160

Adenylyl cyclase 6 improves calcium uptake and left ventricular function in aged hearts.

Tong Tang1, H Kirk Hammond, Amy Firth, Yuan Yang, Mei Hua Gao, Jason X-J Yuan, N Chin Lai.   

Abstract

OBJECTIVES: This study tested the hypothesis that activation of adenylyl cyclase 6 (AC6) expression in cardiac myocytes improves calcium uptake and left ventricular (LV) function in aging mice.
BACKGROUND: Aging hearts exhibit impaired β-adrenergic receptor signaling and LV dysfunction.
METHODS: Twenty-month-old mice with cardiac-directed and regulated AC6 expression were randomized into 2 groups, and AC6 expression was activated in 1 group (AC6-On) but not the other (AC6-Off). One month later, LV function and sarcoplasmic reticulum calcium uptake were assessed.
RESULTS: AC6 expression was associated with increased LV contractility, as reflected by ejection fraction (p = 0.02), rate of pressure development (p = 0.002), and slope of the LV end-systolic pressure-volume relationship (p = 0.04). No changes in LV weight to tibial length ratio, LV fibrosis, and expression of fetal genes (atrial natriuretic factor, α-skeletal muscle actin, and β-myosin heavy chain) and collagens were observed between AC6-On and AC6-Off groups. However, LV samples from AC6-On mice showed increases in: isoproterenol-stimulated cAMP production (p = 0.04), cAMP-dependent protein kinase activity (p < 0.0004), phosphorylation of phospholamban (at Ser16 site; p = 0.04) and cardiac troponin I (at Ser23/24 sites; p = 0.01), velocity of sarcoplasmic reticulum calcium uptake (p < 0.0001), and sarcoplasmic reticulum calcium-ATPase2a (SERCA2a) affinity for calcium (p < 0.0001). Finally, we found that AC6 expression increased sarcoplasmic reticulum calcium storage in cardiac myocytes isolated from 23-month-old rats. In contrast, AC6 expression in 7-month-old mice did not change LV function and calcium uptake.
CONCLUSIONS: These results indicate that activation of cardiac AC6 expression improves impaired function of aged hearts through improved calcium uptake.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527160      PMCID: PMC3087976          DOI: 10.1016/j.jacc.2010.11.052

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  49 in total

1.  Cardiomyopathy induced by cardiac Gs alpha overexpression.

Authors:  M Iwase; M Uechi; D E Vatner; K Asai; R P Shannon; R K Kudej; T E Wagner; D C Wight; T A Patrick; Y Ishikawa; C J Homcy; S F Vatner
Journal:  Am J Physiol       Date:  1997-01

Review 2.  Timing is everything in life: conditional transgene expression in the cardiovascular system.

Authors:  G I Fishman
Journal:  Circ Res       Date:  1998-05-04       Impact factor: 17.367

3.  Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

Authors:  S Engelhardt; L Hein; F Wiesmann; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

4.  Changes in type VI adenylyl cyclase isoform expression correlate with a decreased capacity for cAMP generation in the aging ventricle.

Authors:  K Tobise; Y Ishikawa; S R Holmer; M J Im; J B Newell; H Yoshie; M Fujita; E E Susannie; C J Homcy
Journal:  Circ Res       Date:  1994-04       Impact factor: 17.367

Review 5.  Sympathetic nervous system and aging in man.

Authors:  J W Rowe; B R Troen
Journal:  Endocr Rev       Date:  1980       Impact factor: 19.871

6.  Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function.

Authors:  Merry L Lindsey; Danielle K Goshorn; Christina E Squires; G Patricia Escobar; Jennifer W Hendrick; Joseph T Mingoia; Sarah E Sweterlitsch; Francis G Spinale
Journal:  Cardiovasc Res       Date:  2004-12-13       Impact factor: 10.787

7.  Left ventricular function and remodeling after myocardial infarction in aging rats.

Authors:  T E Raya; M Gaballa; P Anderson; S Goldman
Journal:  Am J Physiol       Date:  1997-12

8.  Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy.

Authors:  D M Roth; M H Gao; N C Lai; J Drumm; N Dalton; J Y Zhou; J Zhu; D Entrikin; H K Hammond
Journal:  Circulation       Date:  1999-06-22       Impact factor: 29.690

9.  Effects of aging on sarcoplasmic reticulum Ca2+-cycling proteins and their phosphorylation in rat myocardium.

Authors:  A Xu; N Narayanan
Journal:  Am J Physiol       Date:  1998-12

10.  Age-related changes in beta-adrenergic neuroeffector systems in the human heart.

Authors:  M White; R Roden; W Minobe; M F Khan; P Larrabee; M Wollmering; J D Port; F Anderson; D Campbell; A M Feldman
Journal:  Circulation       Date:  1994-09       Impact factor: 29.690

View more
  14 in total

Review 1.  Prospects for gene transfer for clinical heart failure.

Authors:  T Tang; M H Gao; H Kirk Hammond
Journal:  Gene Ther       Date:  2012-04-26       Impact factor: 5.250

Review 2.  Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging.

Authors:  Naranjan S Dhalla; Shashanka Rangi; Andrea P Babick; Shelley Zieroth; Vijayan Elimban
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 3.  Cyclic AMP synthesis and hydrolysis in the normal and failing heart.

Authors:  Aziz Guellich; Hind Mehel; Rodolphe Fischmeister
Journal:  Pflugers Arch       Date:  2014-04-24       Impact factor: 3.657

4.  Cardiac adenylyl cyclase overexpression precipitates and aggravates age-related myocardial dysfunction.

Authors:  Nathalie Mougenot; Delphine Mika; Gabor Czibik; Elizabeth Marcos; Shariq Abid; Amal Houssaini; Benjamin Vallin; Aziz Guellich; Hind Mehel; Daigo Sawaki; Grégoire Vandecasteele; Rodolphe Fischmeister; Roger J Hajjar; Jean-Luc Dubois-Randé; Isabelle Limon; Serge Adnot; Geneviève Derumeaux; Larissa Lipskaia
Journal:  Cardiovasc Res       Date:  2019-10-01       Impact factor: 10.787

Review 5.  Gene transfer for congestive heart failure: update 2013.

Authors:  Tong Tang; H Kirk Hammond
Journal:  Transl Res       Date:  2012-12-20       Impact factor: 7.012

Review 6.  Molecular targets in heart failure gene therapy: current controversies and translational perspectives.

Authors:  Victor Kairouz; Larissa Lipskaia; Roger J Hajjar; Elie R Chemaly
Journal:  Ann N Y Acad Sci       Date:  2012-04       Impact factor: 6.499

7.  The type VI adenylyl cyclase protects cardiomyocytes from β-adrenergic stress by a PKA/STAT3-dependent pathway.

Authors:  Yu-Shuo Wu; Chien-Chang Chen; Chen-Li Chien; Hsing-Lin Lai; Si-Tse Jiang; Yong-Cyuan Chen; Lin-Ping Lai; Wei-Fan Hsiao; Wen-Pin Chen; Yijuang Chern
Journal:  J Biomed Sci       Date:  2017-09-04       Impact factor: 8.410

8.  AAV-mediated gene therapy for heart failure: enhancing contractility and calcium handling.

Authors:  Fouad A Zouein; George W Booz
Journal:  F1000Prime Rep       Date:  2013-08-01

9.  Type VI adenylyl cyclase negatively regulates GluN2B-mediated LTD and spatial reversal learning.

Authors:  Ching-Pang Chang; Cheng-Ta Lee; Wen-Hsien Hou; Meng-Syuan Lin; Hsing-Lin Lai; Chen-Li Chien; Chen Chang; Pei-Lin Cheng; Cheng-Chang Lien; Yijuang Chern
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

10.  Cardiac-Directed Expression of Adenylyl Cyclase Catalytic Domain Reverses Cardiac Dysfunction Caused by Sustained Beta-Adrenergic Receptor Stimulation.

Authors:  Mei Hua Gao; N Chin Lai; Dimosthenis Giamouridis; Young Chul Kim; Zhen Tan; Tracy Guo; Wolfgang H Dillmann; Jorge Suarez; H Kirk Hammond
Journal:  JACC Basic Transl Sci       Date:  2016-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.